A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Stopped Lack of potential participants given the other treatment options currently available to people
Conditions
- CLL
- SLL
- CLL/SLL
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
- OTHER: Treatment Free Observation
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators